PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Mus
Go back to PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Mus| (NASDAQ: ELAB) | Delayed: 4.85 -0.36 (6.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.21 | 52 Week High | $ | |||
| Open | $5.21 | 52 Week Low | $ | |||
| Day High | $5.35 | P/E | N/A | |||
| Day Low | $4.82 | EPS | $ | |||
| Volume | 30,180 | |||||
| (NASDAQ: ELAB) | Delayed: 4.85 -0.36 (6.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.21 | 52 Week High | $ | |||
| Open | $5.21 | 52 Week Low | $ | |||
| Day High | $5.35 | P/E | N/A | |||
| Day Low | $4.82 | EPS | $ | |||
| Volume | 30,180 | |||||

